First Recommendations Ever from NCCN

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers— has published its first ever set of treatment recommendations pertaining to neuroblastoma.

Neuroblastoma is a type of solid tumor cancer that typically occurs in early childhood, with the majority diagnosed before age five. It’s also the most common type of solid tumor (outside of brain tumors) in children.

“Neuroblastoma is a biologically and clinically heterogeneous cancer, which creates many challenges for those treating patients with this disease,” said Rochelle Bagatell, MD, Professor of Pediatrics and Solid Tumor Section Chief at Children’s Hospital of Philadelphia, and Chair of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Neuroblastoma. “The NCCN Guidelines were designed to assist clinicians caring for children with neuroblastoma by providing key information regarding risk stratification and by summarizing the data that have led to the current approaches to therapy. As new clinical trial results become available and as therapies evolve, we will continue to support providers by updating the guidelines over time.”

Continuing reading the full new release here.